Surgery without subsequent radiotherapy offers reasonable overall survival outcomes for patients suffering from stage I small cell lung cancer (SCLC), according to the results of a recent study published in the February edition of the Journal of Thoracic Oncology.
Simultaneous use of chemotherapy and high-dose radiotherapy has produced encouraging results in the treatment of limited-stage small-cell lung cancer, according to a phase II study presented Tuesday at the 2009 American Society for Radiation Oncology (ASTRO) meeting in Chicago.
Higher doses of radiation concurrently with chemotherapy improve survival in patients with stage III lung cancer, according to a study published in the April 1 issue of the International Journal of Radiation Oncology*Biology*Physics. However, the potential toxicity associated with higher dose is leading researchers to consider PET imaging to guide more targeted treatment.
|
Written by Editorial Staff
The uptake of the radiopharmaceutical fluoro methyl tyrosine (FMT) on PET imaging in patients with pulmonary adenocarcinoma is a significant independent predictor of poor prognosis, according to research published in this month’s issue of the Journal of Nuclear Medicine.
PET/CT can be used to diagnose lung cancer in a “fast-track” setting, according to a study published in the October issue of the Journal of Thoracic Oncology.
|
RSS 
The use of health IT to reduce rehospitalizations will be welcome but also disruptive, said Stephen Jencks, an independent consultant in healthcare safety during a Feb. 24 webinar on the potential use of health IT to mitigate rehospitalizations, sponsored by the Agency for Healthcare Research and Quality (AHRQ).
During the Health IT Standards Committee meeting on Feb. 24 in Washington, D.C., the Clinical Operations Workgroup sought to gather comments on proposed recommendations on implementation specifications for content exchange, vocabulary and code set standards for the Interim Final Rule of meaningful use.
In 2006, the Center for Devices and Radiological Health (CDRH), a branch of the FDA, began examining the number of medical device reports they received. Over the past two years, the number of submitted reports has increased, sparking a demand for the CDRH to make a move to electronic reporting.
A new hospital breaking ground usually isn’t breaking news. But the vision of patient care at one new facility, tentatively named Palomar Medical Center West (PMC West), is currently illegal under California state law.